Abstract

Local recurrences in patients with grade 4 adult-type diffuse gliomas mostly occur within residual non-enhancing T2 hyperintensity areas after surgical resection. Unfortunately, it is challenging to distinguish non-enhancing tumors from edema in the non-enhancing T2 hyperintensity areas using conventional MRI alone. Quantitative DCE MRI parameters such as Ktrans and Ve convey permeability information of glioblastomas that cannot be provided by conventional MRI. We used the publicly available nnU-Net to train a deep learning model that incorporated both conventional and DCE MRI to detect the subtle difference in vessel leakiness due to neoangiogenesis between the non-recurrence area and the local recurrence area, which contains a higher proportion of high-grade glioma cells. We found that the addition of Ve doubled the sensitivity while nonsignificantly decreasing the specificity for prediction of local recurrence in glioblastomas, which implies that the combined model may result in fewer missed cases of local recurrence. The deep learning model predictive of local recurrence may enable risk-adapted radiotherapy planning in patients with grade 4 adult-type diffuse gliomas.

Details

Title
Added value of dynamic contrast-enhanced MR imaging in deep learning-based prediction of local recurrence in grade 4 adult-type diffuse gliomas patients
Author
Yoon, Jungbin 1 ; Baek, Nayeon 1 ; Yoo, Roh-Eul 2 ; Choi, Seung Hong 3 ; Kim, Tae Min 4 ; Park, Chul-Kee 5 ; Park, Sung-Hye 6 ; Won, Jae-Kyung 6 ; Lee, Joo Ho 7 ; Lee, Soon Tae 8 ; Choi, Kyu Sung 9 ; Lee, Ji Ye 9 ; Hwang, Inpyeong 9 ; Kang, Koung Mi 9 ; Yun, Tae Jin 9 

 Seoul National University College of Medicine, Department of Radiology, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Radiology, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University Hospital, Department of Radiology, Seoul, Republic of Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X) 
 Seoul National University College of Medicine, Department of Radiology, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University Hospital, Department of Radiology, Seoul, Republic of Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X); Institute for Basic Science (IBS), Center for Nanoparticle Research, Seoul, Republic of Korea (GRID:grid.410720.0) (ISNI:0000 0004 1784 4496); Seoul National University, School of Chemical and Biological Engineering, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Internal Medicine, Cancer Research Institute, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Neurosurgery, Biomedical Research Institute, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Pathology, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Radiation Oncology, Cancer Research Institute, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University College of Medicine, Department of Neurology, Seoul, Republic of Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905) 
 Seoul National University Hospital, Department of Radiology, Seoul, Republic of Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X) 
Pages
2171
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2918408462
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.